Home
About Us
Auditors
Directors
Company
Wu Weizhong
Company
Stock Code
From
To
Position(s)
Release Date / Document Links
Reason for Change
NT PHARMA
01011
20-Mar-15
24-Aug-22
ED
24-Aug-22
He wishes to spend more time on the main operation of the Group’s wholly-owned subsidiary